시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 코로나19 항원 검사 시장 보고서(2025년)
COVID-19 Antigen Test Global Market Report 2025
상품코드 : 1824629
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,457,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,334,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,211,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

코로나19 항원 검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 성장률(CAGR) 7.3%를 나타내 100억 8,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 POC(Point-of-Care) 검사 확대, 신형 바이러스 모니터링, 공중 보건 대책, 시장 경쟁, 신형 바이러스 및 지속적인 위협으로 인한 것으로 예측됩니다. 예측 기간 중 주요 동향으로는 차세대 항원 검사 개발 및 승인, 검사 결과 보고를 위한 디지털 및 스마트폰 기술의 통합, 고위험 환경에서의 검사 인프라 확대, 가정용 항원 검사 키트 수요 증가, 합리적인 가격으로 이용하기 쉬운 검사 솔루션의 중시, 변종 특이적 항원 검사의 지속적인 연구 등을 들 수 있습니다.

향후 5년간의 성장률 7.3%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 중국과 독일에서 조달하는 신속 항원 검사 키트의 비용을 밀어 올려 미국의 검사 능력에 부담을 주어 공중 위생 감시 비용을 악화시키고 아웃 브레이크 대응을 늦출 가능성이 높습니다. 또한 상호관세나 무역마찰·제한의 격화에 의한 세계경제·무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.

자기기입식 검사 키트의 인기 급상승이 예상에 따라 코로나19 항원 검사 시장의 향후 성장이 기대됩니다. 자기 관리형 검사 키트는 의료 전문가나 훈련받은 의료 종사자를 필요로 하지 않고 개인이 집에서 직접 사용할 수 있도록 설계된 진단 도구입니다. 자기 기입식 검사 키트의 보급은 코로나19 항원 검사의 보급에 공헌하고, 바이러스의 만연을 늦추는 것과 동시에, 개인이 집에 있으면서 감염을 특정하는 것을 가능하게 합니다. 2022년 4월 미국 질병 예방관리센터에 따르면 델타 우세기(2021년 8월-12월)부터 오미크론 우세기(12월-2022년 3월)에 걸쳐 18세 이상의 미국 성인 사이에서 COVID-19의 가정 내 검사 이용이 대폭 증가했습니다. COVID-19의 증상이 있는 응답자의 집 검사 이용률은 5.7%에서 20.1%로 증가했습니다. 따라서 자기 검사 키트의 보급이 코로나19 항원 검사 시장 성장의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

COVID-19 is an infectious respiratory illness caused by the Severe Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2), affecting the human respiratory system and resulting in infections ranging from the common cold to more severe respiratory diseases. The COVID-19 antigen test serves as a diagnostic tool to identify the presence of specific proteins from the SARS-CoV-2 virus in a person's respiratory specimen. This test typically employs a sample collected from a nasal or throat swab.

The primary products and services associated with COVID-19 antigen tests include platforms, reagents and kits, and various services. Platforms refer to specific technologies or systems utilized for conducting particular tests. Nasopharyngeal swabs, oropharyngeal swabs, and nasal swab specimens are commonly used by clinics, hospitals, home care services, diagnostic labs, and other end-users in the process of conducting COVID-19 antigen tests.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The COVID-19 antigen testsCOVID-19 antigen tests market research report is one of a series of new reports from The Business Research Company that provides COVID-19 antigen testsCOVID-19 antigen tests market statistics, including COVID-19 antigen testsCOVID-19 antigen tests industry global market size, regional shares, competitors with a COVID-19 antigen testsCOVID-19 antigen tests market share, detailed COVID-19 antigen testsCOVID-19 antigen tests market segments, market trends and opportunities, and any further data you may need to thrive in the COVID-19 antigen testsCOVID-19 antigen tests industry. This COVID-19 antigen testsCOVID-19 antigen tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The covid-19 antigen test market size has grown strongly in recent years. It will grow from $7.13 billion in 2024 to $7.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to pandemic outbreak, emergency regulatory approvals, supply chain challenges, government initiatives, global vaccination efforts.

The covid-19 antigen test market size is expected to see strong growth in the next few years. It will grow to $10.08 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to point-of-care testing expansion, new variants surveillance, public health measures, market competition, emerging variants and continued threat. Major trends in the forecast period include development and approval of next-generation antigen tests, integration of digital and smartphone technologies for test result reporting, expansion of testing infrastructure in high-risk settings, increasing demand for home-based antigen test kits, emphasis on affordable and accessible testing solutions, continuous research for variants-specific antigen tests.

The forecast of 7.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. testing capacity by driving up the cost of rapid antigen test kits sourced from China and Germany, exacerbating public health surveillance costs and delaying outbreak responses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in popularity of self-administered test kits is expected to drive the growth of the COVID-19 antigen test market in the future. Self-administered test kits are diagnostic tools designed for individuals to use on themselves at home, eliminating the need for medical professionals or trained personnel. The increased adoption of self-administered test kits contributes to the wider availability of COVID-19 antigen tests, aiding in slowing the spread of the virus and enabling individuals to identify infections in the comfort of their homes. According to the Centers for Disease Control and Prevention in April 2022, there was a significant rise in the use of at-home COVID-19 tests among U.S. adults aged 18 and older during the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). The use of at-home tests among respondents with COVID-19-such as symptoms increased from 5.7% to 20.1%. Therefore, the increasing popularity of self-administered test kits is a driving force behind the growth of the COVID-19 antigen test market.

An upsurge in testing rates is anticipated to fuel the growth of the COVID-19 antigen test market in the future. Testing rates represent the frequency of diagnostic tests, such as COVID-19 tests, performed within a given population or over a specific period. As testing rates increase, there is a growing demand for COVID-19 testing solutions, including antigen tests. This heightened demand directly contributes to the market's expansion, requiring manufacturers and suppliers to produce and distribute more tests to meet the rising needs. According to the National Institutes of Health in October 2023, the total COVID-19 testing rate ranged from 5.13 to 22,386.63 per 1000 people from October 2022 to October 2023. Therefore, the increase in testing rates is a key driver of the COVID-19 antigen test market's growth.

In July 2022, Meridian Bioscience Inc., a U.S.-based company, announced a definitive merger agreement with SD Biosensor Inc., located in South Korea, and SJL Partners LLC, also based in Seoul, South Korea. This strategic initiative, spearheaded by a consortium including SD Biosensor and SJL, aims to enhance Meridian's ability to serve its customers as it shifts away from the peak demand for COVID-19 testing. Furthermore, this merger will facilitate the development of new diagnostic products by leveraging SD Biosensor's industry expertise and complementary offerings, thereby expanding the companies' reach and fostering innovation in the diagnostics market.

Major companies operating in the COVID-19 antigen test market report are F. Hoffmann-La Roche AG, Abbott Laboratories, Becton And Dickinson and Company, Laboratory Corporation Of America, PerkinElmer Inc., Quidel Corporation, SD Biosensor Inc., Diasorin S.P.A, Biosynex Swiss SA, iHealth Labs Inc., Everlywell Inc., JOYSBIO Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt. Ltd., Access Bio Inc., RayBiotech Life Inc., CTK Biotech Inc., Artron Laboratories Inc., Princeton BioMeditech Corporation, ACON Laboratories Inc., BioLytical Laboratories Inc., BioNote Inc., Assure Tech (Hangzhou) Co. Ltd., ADS biotech Inc., ANP Technologies Inc., BTNX Inc., Cellspect Co.Ltd., Empowered Diagnostics LLC, GenBody Inc., Beijing Wantai Biologicalpharmacy Enterprise Co. Ltd.

Asia-Pacific was the largest region in the COVID-19 antigen test market in 2024. The regions covered in the COVID-19 antigen test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 antigen test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 antigen test market consists of revenues earned by entities by providing services such as point-of-care testing (POC), telehealth services, travel testing services, and healthcare provider testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 antigen test market also includes sales of sample collection devices, extraction kits, buffers and solutions, and control materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Antigen Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 antigen test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for covid-19 antigen test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The covid-19 antigen test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. COVID-19 Antigen Test Market Characteristics

3. COVID-19 Antigen Test Market Trends And Strategies

4. COVID-19 Antigen Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global COVID-19 Antigen Test Growth Analysis And Strategic Analysis Framework

6. COVID-19 Antigen Test Market Segmentation

7. COVID-19 Antigen Test Market Regional And Country Analysis

8. Asia-Pacific COVID-19 Antigen Test Market

9. China COVID-19 Antigen Test Market

10. India COVID-19 Antigen Test Market

11. Japan COVID-19 Antigen Test Market

12. Australia COVID-19 Antigen Test Market

13. Indonesia COVID-19 Antigen Test Market

14. South Korea COVID-19 Antigen Test Market

15. Western Europe COVID-19 Antigen Test Market

16. UK COVID-19 Antigen Test Market

17. Germany COVID-19 Antigen Test Market

18. France COVID-19 Antigen Test Market

19. Italy COVID-19 Antigen Test Market

20. Spain COVID-19 Antigen Test Market

21. Eastern Europe COVID-19 Antigen Test Market

22. Russia COVID-19 Antigen Test Market

23. North America COVID-19 Antigen Test Market

24. USA COVID-19 Antigen Test Market

25. Canada COVID-19 Antigen Test Market

26. South America COVID-19 Antigen Test Market

27. Brazil COVID-19 Antigen Test Market

28. Middle East COVID-19 Antigen Test Market

29. Africa COVID-19 Antigen Test Market

30. COVID-19 Antigen Test Market Competitive Landscape And Company Profiles

31. COVID-19 Antigen Test Market Other Major And Innovative Companies

32. Global COVID-19 Antigen Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Antigen Test Market

34. Recent Developments In The COVID-19 Antigen Test Market

35. COVID-19 Antigen Test Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기